Daré Bioscience (Cerulean)
AcquiredSan Diego, United States · Founded 2017 · $21.5M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $21.5M
- Last Round
- $11.5M GrantJul 2021
- Rounds
- 2
About
Women's health biopharmaceutical company developing and commercializing innovative therapies for reproductive health, contraception, and vaginal conditions.
Summary
Daré Bioscience (Cerulean) is a Biotech company based in San Diego, United States, founded in 2017. It has raised $21.5M in total across 2 rounds, most recently a $11.5M Grant round in Jul 2021. Investors include Bill & Melinda Gates Foundation, Lincoln Park Capital and Polaris Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2021
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...